Latest PRCT news and sentiment

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC is reminding investors who suffered substantial losses in PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to file lead plaintiff applications by September 22, 2026, in a securities class action lawsuit. The lawsuit alleges that Procept failed to disclose that its U.S. handpiece sales materially exceeded procedures since Q1 2023, leading to an excess inventory of over 10,000 units. This undisclosed inventory glut resulted in a significant decline in quarterly handpiece unit sales and an 18% drop in stock price after the company announced its Q4 2025 earnings.

PROCEPT BioRobotics Corporation Notice of September 22, 2026 Application Deadline for Class Action Lawsuit - Contact Reed Kathrein at Hagens Berman Sobol Shapiro LLP Before Application Deadline

Hagens Berman Sobol Shapiro LLP has filed a securities class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased shares between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT misled investors regarding its handpiece sales practices, particularly by using extensive discount programs to artificially inflate reported unit sales and revenues. Investors suffered substantial losses as partial disclosures about deteriorating sales performance and excess customer inventory drove down the stock price.

SueWallSt Reminds PROCEPT BIOROBOTICS CORPORATION Investors of the Pending Class Action Lawsuit With a Lead Plaintiff Deadline of September 22, 2026 - PRCT

PRCT DEADLINE: ROSEN, A LEADING LAW FIRM Encourages PROCEPT

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered losses exceeding $100K to secure counsel before the September 22, 2026, lead plaintiff deadline. The firm reminds purchasers of PRCT common stock between February 28, 2024, and February 25, 2026, about a securities class action lawsuit. The lawsuit alleges that PROCEPT made materially false and/or misleading statements regarding an undisclosed discount program that artificially inflated handpiece unit sales and revenues.

PRCT Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against PROCEPT BioRobotics Corporation and Announces Opportunity for Investors with Substantial Losses to Lead Class Action Lawsuit

Robbins Geller Rudman & Dowd LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT made materially false and misleading statements regarding its U.S. handpiece unit sales and revenue, primarily due to an undisclosed discount program that artificially inflated sales and created a surplus of inventory. Investors with substantial losses during this period have until September 22, 2026, to seek appointment as lead plaintiff.

PROCEPT CLASS ACTION ALERT: Bragar Eagel & Squire, P.C.

Bragar Eagel & Squire, P.C. has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that Procept misled investors by failing to disclose an extensive discount program that artificially inflated sales and revenues, leading to an overstock of inventory. Investors who suffered losses are encouraged to contact the law firm to discuss their legal options and apply to be lead plaintiff by September 22, 2026.

Kaplan Fox Encourages Investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to Contact the Firm to Learn About Their Legal Rights

Kaplan Fox & Kilsheimer LLP has filed a class action lawsuit against PROCEPT BioRobotics Corporation (NASDAQ: PRCT) on behalf of investors who purchased common stock between February 28, 2024, and February 25, 2026. The lawsuit alleges that PROCEPT artificially inflated its reported U.S. handpiece unit sales and revenues by using undisclosed sales tactics, specifically a discount program that caused handpiece orders to materially exceed procedures. Investors who suffered losses are encouraged to contact Kaplan Fox to learn about their legal rights and the lead plaintiff process, with a deadline of September 22, 2026, to move the court as a lead plaintiff.

Lost Money on PROCEPT BioRobotics Corporation (PRCT)? Join Class Action Suit Seeking Recovery - Contact The Gross Law Firm

The Gross Law Firm has issued a notice to shareholders of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The suit alleges that PROCEPT BioRobotics Corporation made false or misleading statements regarding an undisclosed discount program that inflated sales and revenue, leading to a surplus of inventory and inability to meet sales guidance. Shareholders who purchased PRCT shares between February 28, 2024, and February 25, 2026, are encouraged to contact the firm by the September 22, 2026, deadline to register for the class action.

PRCT Investor Announcement: PROCEPT BioRobotics Sued on behalf of Investors to Recover Losses after Artificially Inflated Revenue Leads to 18% Stock Drop

Why PROCEPT BioRobotics (PRCT) Is Up 9.6% After Reaffirming 2026 Revenue Guidance Despite Wider Losses

PROCEPT BioRobotics (PRCT) saw its stock rise 9.6% despite reporting wider net losses in Q2 2026, driven by reaffirming its full-year 2026 revenue guidance of US$390 million to US$410 million. The company's investment narrative centers on Aquablation adoption and the path to sustainable profitability, with analysts noting both optimistic and cautious outlooks regarding future growth, competition, and pricing pressures. The reaffirmed guidance suggests management anticipates continued demand momentum even as losses expand.

PROCEPT BioRobotics Corporation Investors: September 22, 2026, Deadline in Securities Fraud Class Action Lawsuit - Contact Kessler Topaz Meltzer & Check, LLP

Affected PRCT Investor Summary Who: PROCEPT BioRobotics Corporation (NASDAQ: PRCT)What: Securities fraud class action lawsuit filedClass Period: February 28, 2024 through February 25, 2026Deadline to Seek Lead Plaintiff Status: September 22, 2026Key Lawsuit Allegations: Material misstatements and/or omissions concerning the company’s product demandInvestor Action: Contact Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) for recovery options RADNOR, Pa., Aug. 09, 2026 (GLOBE NEWSWIRE) -- Kessler Topaz Meltzer & Check, LLP (www.ktmc.com), a nationally recognized securities litigation law firm,

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages PROCEPT BioRobotics Corporation Investors to ...

The Rosen Law Firm is encouraging investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) to join a class action lawsuit. The lawsuit alleges that PROCEPT made materially false and misleading statements about an extensive discount program which artificially inflated reported sales and revenue between February 28, 2024, and February 25, 2026. Investors who purchased stock during this period have until September 22, 2026, to move for lead plaintiff.

PROCEPT BioRobotics (PRCT) Stock Sees Fair Value Falls As Analysts Cut Growth Views

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Price targets for PROCEPT BioRobotics have been reset closer to its revised fair value, with many now clustered in the low to mid US$20s instead of around US$30. Analysts linking these lower targets to slower procedure trends, competition risk and the overhang from recent legal actions have shifted several ratings to Hold, Neutral or Market Perform. As you read on, you will see how this evolving analyst narrative may shape how you track PROCEPT BioRobotics

PROCEPT BioRobotics Corporation Securities Fraud Class Action Result of Undisclosed Inventory Issues and Approximately 18% Stock Decline - Investors May Contact Lewis Kahn, Esq, at Kahn Swick & Foti, LLC

Kahn Swick & Foti, LLC (KSF) is reminding investors of PROCEPT BioRobotics Corporation (NASDAQ: PRCT) who suffered substantial losses to file lead plaintiff applications by September 22, 2026, in a securities class action lawsuit. The lawsuit alleges that Procept failed to disclose material information regarding excess inventory and a significant decline in handpiece sales, which led to a more than 18% stock drop. Investors who purchased shares between February 28, 2024, and February 25, 2026, are encouraged to contact KSF to discuss their legal rights.